Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Burbank, California Clinical Trials

A listing of Burbank, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (22) clinical trials

Study to Characterize Puffing Topography With Use of JUUL Electronic Nicotine Delivery Systems (ENDS) in Adult Closed-System ENDS Consumers

Subjects who successfully complete screening procedures, including a brief trial with each of the JUUL flavors at the 5% strength, will be eligible to participate in the study. Subjects will be randomized into one of two (2) groups (Virginia Tobacco and Menthol or Mint and Mango, each at both nicotine ...

Phase N/A

2.17 miles

Learn More »

Testing the Addition of a New Anti-cancer Drug Venetoclax to Usual Chemotherapy for High Grade B-cell Lymphomas

PRIMARY OBJECTIVES: I. To compare the progression-free survival (PFS) of rituximab (R)-chemotherapy plus venetoclax versus R-chemotherapy alone in MYC/BCL2 double-hit and double expressing lymphomas. SECONDARY OBJECTIVES: I. To compare the overall survival (OS) of R-chemotherapy plus venetoclax versus R-chemotherapy alone in MYC/BCL2 double-hit and double expressing lymphomas. (Key Secondary Objective) ...

Phase

2.17 miles

Learn More »

The Object of This Study is to Evaluate the Efficacy Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone

Phase

4.72 miles

Learn More »

A Study Investigating the Effectiveness of a LifeSeasons NeuroQ Supplement With Lifestyle Changes to Improve Cognitive Function in Healthy Adults Who Have One or More Risk Factors for Cognitive Decline

The objective of this study is to evaluate the efficacy of a NeuroQ supplement designed by Dr. Bredesen to complement his Lifestyle modification protocol. Eligible participants will be expected to consume the NeuroQ supplement and are recommended to make lifestyle changes based on Dr. Bredesen's protocol. Forty participants are expected ...

Phase N/A

5.38 miles

Learn More »

Hospital-Based Cluster Trial: Magnetically Controlled Growing Rods Using Distraction Intervals

The Magnetically Controlled Growing Rod (MCGR) system consists of growing rods similarly implanted as with traditional approaches, but with subsequent noninvasive distractions. The implanted growing rods are magnetically controlled and adjusted outside the body using an external remote controller (ERC) following initial surgical insertion. No incision or anesthesia are used ...

Phase N/A

5.39 miles

Learn More »

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)

The purpose of this study is to evaluate the safety and tolerability of a 3-day intravenous (IV) fosaprepitant (MK-0517) regimen for the prevention of CINV in pediatric participants scheduled to receive emetogenic chemotherapy.

Phase

5.39 miles

Learn More »

Study With Lu AF87908 in Healthy Subjects and Patients With Alzheimer's Disease

The study will be divided into three parts: Part A, Part B and Part C. Part A consists of up to 5 sequential cohorts (Cohorts A1 to A5): -Cohorts A1 to A5: 8 healthy subjects per cohort (aiming for an equal number of men and women): 6 randomized to Lu ...

Phase

5.89 miles

Learn More »

Apyx Plasma/RF Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region

This is a prospective, multi-center, multi-phase, evaluator-blinded study of subjects undergoing a procedure to improve the appearance of lax tissue in the neck and submental region. All study subjects will be treated with the Apyx Plasma/RF Device. Phase I (n=20) of this study will be conducted primarily to provide safety ...

Phase N/A

7.4 miles

Learn More »

Safety Tolerability and Efficacy of Monotherapy and Combination Regimens in Adults With Nonalcoholic Steatohepatitis (NASH)

The primary objective of this study is to evaluate the safety and tolerability of study drug(s) in adults with nonalcoholic steatohepatitis (NASH).

Phase

8.0 miles

Learn More »

Study of MT-5111 in HER2-positive Solid Tumors

This study will be conducted in two sequential parts: Part 1 (Dose Escalation): The purpose of Part 1 is to determine the Phase 2 dose (RP2D) to be used in Part 2. Part 1 will include any type of HER2-positive solid cancer. Part 2 (Dose Expansion): The purpose of Part ...

Phase

8.23 miles

Learn More »